Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The hypothesis of the proposed intervention is that Granulocyte-macrophage colony-stimulating factor (GM-CSF) has profound effects on antiviral immunity, and can provide the stimulus to restore immune homeostasis in the lung with acute lung injury post COVID-19, and can promote lung repa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Trials
Main Authors: Bosteels, Cedric, Maes, Bastiaan, Van Damme, Karel, De Leeuw, Elisabeth, Declercq, Jozefien, Delporte, Anja, Demeyere, Bénédicte, Vermeersch, Stéfanie, Vuylsteke, Marnik, Willaert, Joren, Bollé, Laura, Vanbiervliet, Yuri, Decuypere, Jana, Libeer, Frederick, Vandecasteele, Stefaan, Peene, Isabelle, Lambrecht, Bart
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Letter
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273817/
https://ncbi.nlm.nih.gov/pubmed/32503663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04451-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares